Canine Fractalkine/CX3CL1 recombinant protein

Canine Fractalkine/CX3CL1 recombinant protein

• DataSheet
• Material Safety Data Sheets (MSDS)

Fractalkine or Chemokine (C-X3-C motif) ligand 1 (CX3CL1) is a member of the CX3C chemokine family. Fractalkine / CX3CL1 is a unique chemokine that functions not only as a chemoattractant but also as an adhesion molecule and is expressed on endothelial cells activated by proinflammatory cytokines, such as interferon-gamma and tumor necrosis factor-alpha. Fractalkine/CX3CL1 is expressed in a membrane-bound form on activated endothelial cells and mediates attachment and firm adhesion of T cells, monocytes and NK cells. Fractalkine / CX3CL1 is associated with dendritic cells (DC) in epidermis and lymphoid organs. The fractalkine receptor, CX3CR1, is expressed on cytotoxic effector lymphocytes, including natural killer (NK) cells and cytotoxic T lymphocytes, which contain high levels of intracellular perforin and granzyme B, and on macrophages. Soluble fractalkine causes migration of NK cells, cytotoxic T lymphocytes, and macrophages, whereas the membrane-bound form captures and enhances the subsequent migration of these cells in response to secondary stimulation with other chemokines.

Chemokine (C-X3-C motif) ligand 1

D8BWG0439E; CXC3C; ABCD-3; CX3C; C3XKINE; CXC3; AB030188; NTN; CX3CL1; SCYD1; NEUROTACTIN; NTT; AI848747; FRACTALKINE

H1ADY9

cx3cl1

Human Cells

A DNA sequence encoding the canine CX3CL1 (H1ADY9) (Met1-Arg379) was expressed with six amino acids (LEVLFQ) at the C-terminus.

Canine

The recombinant canine CX3CL1 is a disulfide-linked homodimer. The reduced monomer comprises 362 amino acids and has a predicted molecular mass of 38.2 kDa. The apparent molecular mass of the protein is approximately 64-69 kDa in SDS-PAGE under reducing conditions.

> 95 % as determined by SDS-PAGE